CYTEK BIOSCIENCES, INC. (CTKB) Free cash flow 2020–2025
CYTEK BIOSCIENCES, INC. (CTKB) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$8.8MFY2025 · since FY2020: $13.6M → -$8.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$8.8M | -140.1% |
| FY2024 | $21.9M | +3352.4% |
| FY2023 | $633,000 | +102.9% |
| FY2022 | -$22.0M | -8362.8% |
| FY2021 | $266,000 | -98.0% |
| FY2020 | $13.6M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More CTKB financial trends
CTKB RevenueCTKB Net incomeCTKB Net marginCTKB Gross profitCTKB Gross marginCTKB Operating incomeCTKB Operating marginCTKB Operating cash flowCTKB Capital expendituresCTKB Return on equityCTKB Stock buybacksCTKB Dividends paidCTKB Total assetsCTKB Total liabilitiesCTKB Shareholders’ equityCTKB overview →